Life Sciences
The Biomedical Diagnostics Institute (BDI)
The Biomedical Diagnostics Institute (BDI) is an Academic-Industrial-Clinical partnership that is focussed on the development of next generation point-of-care biomedical diagnostics devices. These devices are targeted at point of care applications, including near patient testing, self-testing in the home, and diagnosis of disease in the low resource environments of the developing world.
|
THE BIOMEDICAL DIAGNOSTICS INSTITUTE OVERVIEW |
Biomedical Diagnostics Technologies
| Rapid Assessment of Platelets in Disease | ||
| DCU and the Royal College of Surgeons in Ireland (RCSI) through their partnership at the Biomedical Diagnostics Institute (BDI) have developed a novel assay that rapidly assesses and characterises an individual’s platelet function by capturing and enumerating single platelets on a protein surface. | ||
|
Rapid Assessment of Platelets in Disease | |
| Platelet Function Assay | ||
DCU and the Royal College of Surgeons in Ireland (RCSI) through their partnership at the Biomedical Diagnostics Institute (BDI) have developed a novel platelet function assay that characterises the behaviour of platelets under arterial shear conditions. |
||
|
Platelet Function Assay | |
| High Brightness Nanoparticles for Fluorescent Labelling | ||
The researchers at the Biomedical Diagnostics Institute at DCU have developed proprietary silica nanoparticles which are doped with fluorescent dyes in order to provide high brightness fluorescent labels for range of application, primarily in the diagnostics and pharmaceutical industries. |
||
|
High Brightness Nanoparticles for Fluorescent Labelling | |
| Imaging Dyes | ||
DCU and the Royal College of Surgeons in Ireland (RCSI) through their partnership at the Biomedical Diagnostics Institute (BDI) have developed novel inorganic metal complexes that can be used simultaneously for luminescence and resonance Raman imaging of cells. |
||
|
Imaging Dyes | |
